CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- Open-market buys, last 90 days
- $1,379,662
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,379,662. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-01 | Booth Andrew Chief Financial Officer | Grant or award · Share Options (right to buy) | +485,661 | 5,870,481 | ||
| 2022-12-01 | Hansen Carl L. G. Chief Executive Officer | Grant or award · Share Options (right to buy) | +925,069 | 6,613,691 | ||
| 2022-11-18 | Hansen Carl L. G. Chief Executive Officer | Option exercise | +56,125 | $2.70 | $152K | 449,000 |
| 2022-11-18 | Hansen Carl L. G. Chief Executive Officer | Option exercise · Share option (right to buy) | −56,125 | 5,688,622 | ||
| 2022-10-31 | Thermopylae Holdings Ltd. 10% owner | Gift | −70,000 | 55,774,391 | ||
| 2022-08-19 | Thermopylae Holdings Ltd. 10% owner | Purchase | +200,000 | $11.46 | $2.3M | 55,844,391 |
| 2022-08-18 | Hansen Carl L. G. Chief Executive Officer | Option exercise | +56,125 | $2.70 | $152K | 392,875 |
| 2022-08-18 | Hansen Carl L. G. Chief Executive Officer | Option exercise · Share option (right to buy) | −56,125 | 5,744,747 | ||
| 2022-06-14 | Thermopylae Holdings Ltd. 10% owner | Purchase | +9,173 | $8.05 | $74K | 55,644,391 |
| 2022-06-13 | Thermopylae Holdings Ltd. 10% owner | Purchase | +54,915 | $8.03 | $441K | 55,635,218 |
| 2022-06-06 | Thermopylae Holdings Ltd. 10% owner | Purchase | +64,545 | $7.50 | $484K | 55,580,303 |
| 2022-05-18 | Hansen Carl L. G. Chief Executive Officer | Option exercise | +56,125 | $2.70 | $152K | 336,750 |
| 2022-05-18 | Hansen Carl L. G. Chief Executive Officer | Option exercise · Share option (right to buy) | −56,125 | 5,800,872 | ||
| 2022-05-16 | Lecault Veronique Chief Operating Officer | Purchase | +200,000 | $6.34 | $1.3M | 1,770,122 |
| 2022-05-13 | Thermopylae Holdings Ltd. 10% owner | Purchase | +300,000 | $7.26 | $2.2M | 55,515,758 |
| 2022-05-12 | Thermopylae Holdings Ltd. 10% owner | Purchase | +1,408,468 | $6.41 | $9.0M | 55,215,758 |
| 2022-05-12 | Booth Andrew Chief Financial Officer | Purchase | +85,000 | $5.79 | $492K | 138,500 |
| 2022-03-04 | Montalbano John S. Director | Purchase | +10,000 | $8.54 | $85K | 56,000 |
| 2022-03-01 | Montalbano John S. Director | Purchase | +20,000 | $9.05 | $181K | 46,000 |
| 2022-02-28 | Lecault Veronique Chief Operating Officer | Purchase | +230,789 | $8.66 | $2.0M | 1,570,122 |
Page 5 of 11 · 203 trades